The Hippo pathway limits organ size and suppresses tumors. Reporting in Cell, Moroishi et al. (2016), show that, paradoxically, Hippo pathway inactivation can repress tumor growth by modulating tumor immunogenicity. This could explain the rarity of pathway mutations in cancers and suggests Hippo pathway repression as a cancer immunotherapy modality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.devcel.2016.12.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!